Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine
 Disease Category: Breast Cancer
Location: United States, CA

Trial Information

Impact of Adjuvant Chemotherapy on Metabolic Syndrome Risk Factors in Breast Cancer Patients

You have been asked to participate in this research study because you are a woman who has been diagnosed with stage I-III invasive breast cancer, have had a lumpectomy or mastectomy, and will be treated with chemotherapy. The purpose of this study is to assess the effect of chemotherapy treatment on metabolic syndrome risk factors (weight, blood pressure, biomarkers in the blood) in research participants with pre-menopausal and post-menopausal early stage breast cancer. Your participation in this study is expected to last for about 3 to 6 months, until the end of chemotherapy.

Patient Inclusion/Exclusion Criteria:


- See http://clinicaltrials.coh.org for additional information.


City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Map

Research Center Information: City of Hope

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.